A prospective case control study of resistance to rifampicin, dapsone and ofloxacin in Type 1 and Type 2 leprosy reactions and the therapeutic impact of modified treatment regimen on reactions-Reference-Cited by-同舟云学术

A prospective case control study of resistance to rifampicin, dapsone and ofloxacin in Type 1 and Type 2 leprosy reactions and the therapeutic impact of modified treatment regimen on reactions

Published:2022-11-10 Issue:2 Volume:37 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Muddebihal Aishwarya¹,Sardana Kabir¹^ORCID,Khurana Ananta¹^ORCID,Sachdeva Soumya¹,Singh Itu²,Ahuja Madhvi²,Sharma Rahul²

Affiliation:

1. Department of Dermatology, Venereology and Leprosy Dr Ram Manohar Lohia Hospital and Atal Bihari Vajpayee Institute of Medical Sciences New Delhi India

2. Stanley Browne Laboratory The Leprosy Mission Community Hospital New Delhi India

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18709

Reference10 articles.

1. Understanding the type 1 reactional state for early diagnosis and treatment: a way to avoid disability in leprosy

2. Anti‐Microbial Resistance in Leprosy Report of the virtual consultation New Delhi India 14–17 June 2021. Document no.: SEA/GLP/7 © World Health Organization 2021.

3. The histological course of reactions in borderline leprosy and their outcome;Ridley DS;Int J Lepr Other Mycobact Dis,1981

4. A leprosy clinical severity scale for erythema nodosum leprosum: An international, multicentre validation study of the ENLIST ENL Severity Scale

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of drug resistance in leprosy: disease course, reactions and the use of novel drugs;International Journal of Dermatology;2024-09-11

2. The perils of prescribing second line anti-leprosy therapy for erythema nodosum leprosum ignoring resistance testing data;Indian Journal of Dermatology, Venereology and Leprology;2024-05-29

3. High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: An indication to revisit second line anti-leprosy treatment regimen;Journal of Global Antimicrobial Resistance;2023-12

4. Time to revisit the purported link of leprosy reactions with infective triggers: An unnecessary economic burden for patients;Tropical Doctor;2023-11-03